cytidine monophosphate has been researched along with Granulocytic Leukemia in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (40.00) | 18.7374 |
1990's | 2 (40.00) | 18.2507 |
2000's | 1 (20.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kamiya, K; Kawai, Y; Nakamura, T; Sugiyama, M; Tsutani, H; Ueda, T; Urasaki, Y; Wataya, S | 1 |
Braess, J; Freund, M; Hanauske, A; Heil, G; Hiddemann, W; Kaufmann, C; Kern, W; Schleyer, E; Schüssler, M | 1 |
Leen, R; van Gennip, AH; van Kuilenburg, AB; Verschuur, AC; Voûte, PA | 1 |
Drake, WP; Kopyta, LP; Levy, CC; Mardiney, MR | 1 |
Bianchi, U; Calabrese, G; Ferrucci, L; Guanciali-Franchi, P; Mezzanotte, R; Palka, G; Stuppia, R; Sumner, AT; Vanni, R | 1 |
1 trial(s) available for cytidine monophosphate and Granulocytic Leukemia
Article | Year |
---|---|
Oral cytarabine ocfosfate in acute myeloid leukemia and non-Hodgkin's lymphoma--phase I/II studies and pharmacokinetics.
Topics: Acute Disease; Administration, Oral; Adult; Antineoplastic Agents; Arabinonucleotides; Biological Availability; Cytarabine; Cytidine Monophosphate; Diarrhea; Dose-Response Relationship, Drug; Half-Life; Humans; Infusions, Intravenous; Leukemia, Myeloid; Lymphoma, Non-Hodgkin; Metabolic Clearance Rate; Prodrugs; Regression Analysis | 1998 |
4 other study(ies) available for cytidine monophosphate and Granulocytic Leukemia
Article | Year |
---|---|
Clinical pharmacology of 1-beta-D-arabinofuranosylcytosine-5'-stearylphosphate, an orally administered long-acting derivative of low-dose 1-beta-D-arabinofuranosylcytosine.
Topics: Acute Disease; Adult; Aged; Anemia, Refractory, with Excess of Blasts; Antineoplastic Agents; Arabinonucleotides; Cytidine Monophosphate; Female; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid; Male; Middle Aged; Polycythemia Vera | 1994 |
Cyclopentenyl cytosine increases the phosphorylation and incorporation into dna of arabinofu-ranosyl cytosine in a myeloid leukemic cell-line.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Carbon-Nitrogen Ligases; Cytarabine; Cytidine; Cytidine Diphosphate; Cytidine Monophosphate; Deoxycytosine Nucleotides; DNA; Dose-Response Relationship, Drug; Enzyme Inhibitors; HL-60 Cells; Humans; Leukemia, Myeloid; Phosphorylation | 2000 |
Alterations in ribonuclease activities in the plasma, spleen, and thymus of tumor-bearing mice.
Topics: Adenocarcinoma; Adenosine Monophosphate; Animals; Cell Line; Cytidine Monophosphate; Leukemia, Myeloid; Lymphoma, Non-Hodgkin; Melanoma; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Neoplasm Proteins; Neoplasm Transplantation; Neoplasms, Experimental; Ribonucleases; Sarcoma, Experimental; Spleen; Thymus Gland; Transplantation, Homologous; Uridine Monophosphate | 1975 |
Effect of HpaII and MspI restriction endonucleases on chronic myelogenous leukemia chromosomes. Detection of CpG dinucleotide demethylation in situ.
Topics: Cytidine Monophosphate; Cytosine Nucleotides; Deoxyribonuclease HpaII; Dinucleoside Phosphates; DNA Restriction Enzymes; DNA, Neoplasm; Guanosine; Humans; Karyotyping; Leukemia, Myeloid; Staining and Labeling | 1988 |